Roxadustat advances as a promising oral treatment for anemia in lower-risk myelodysplastic syndromes, targeting high ...

Investing.com -- FibroGen Inc (NASDAQ: FGEN) stock jumped 9.9% following positive feedback from the U.S. Food and Drug Administration supporting the advancement of roxadustat for treating anemia in ...

According to KEM doctors, the patient received one unit of ‘O’ Positive whole blood from Shatabdi BDBA Hospital, Kandivali. But, the case has exposed how poorly equipped civic- and state-run hospitals ...

Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course ...

If you’ve ever been elbows-deep in a pediatric spinal deformity correction thinking, “We are rapidly running out of ...

Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for HyHub TM and HyHub TM Duo, devices for patients 17 years of age and older ...

FibroGen has reached agreement with the FDA on important design elements for a pivotal Phase 3 clinical trial for roxadustat for the treatment of anemia in patients with lower-risk myelodysplastic ...

Spain has lifted a long-term blood donation ban on British nationals and former UK residents who lived in the country during ...

Challenges persist despite promising advance In January 2025, the National Institute for Health and Care Excellence (NICE) approved the use of the gene editing therapy exagamglogene autotemcel ...

Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced the appointment of Harout Semerjian as ...

The Church’s recent donation to the American Red Cross will provide additional blood collection equipment, including platelet collection devices and red blood cell collection machines.